Dr Lee Middleton is a medical officer working for Glasgow Alcohol and Drug Recovery service, and has been a specialist in the treatment of substance misuse in the city for over 15 years. Particular areas of interest during this time have been increasing blood borne virus testing rates in the community on the background of the HIV increase in Glasgow, and improving access to and engagement with hepatitis C treatment in the local care and treatment teams. She was also involved in piloting the use of long-acting buprenorphine in Glasgow in 2019, one of the first uses of this treatment in the UK, and is currently based in the Glasgow Alcohol and Drugs Crisis Service.
Review of the first six months of a residential drug stabilisation service
Aim The aim of this piece of work is to evaluate the first six months of direct access to the Stabilisation Service in Glasgow (admission from community). The Stabilisation Service is a residential project with 10 beds at present, which offers a six weeks stay supported by nursing and project staff, with a primary focus of supporting individuals to stabilise their drug and alcohol use. This may include optimising medication assisted treatment (MAT), managing benzodiazepine use through detox or stabilised dosing (with a view to possible future community detox), and medication-assisted detox from alcohol, including the commencement of protective medication.
Methods Data from all direct admissions from the community to the Stabilisation Service will be collated and analysed. This will encompass the 3 months prior to admission and 3 months post discharge, and will consider parameters including:- demographics (age, sex, gender)- MAT type/dose- reported drug use- overdose (non-fatal/fatal)- discharge type (planned/unplanned)- engagement with recovery supports
Results Results pending due to timescale of project and will be available at time of presentation. Conclusions Analysis of results pending, as per above.